Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global Embolization Particle market is projected to reach US$ 5248.9 million by 2030 from an estimated US$ 2329.4 million in 2024, at a CAGR of 14.5% during 2024 and 2030.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Embolization Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Embolization Particle.
The Embolization Particle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Embolization Particle market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolization Particle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
麻豆原创 Segmentation
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Segment by Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Embolization Particle in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Embolization Particle sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Embolization Particle Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Embolization Particle 麻豆原创 Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 麻豆原创 by Application
1.3.1 Global Embolization Particle 麻豆原创 Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Embolization Particle 麻豆原创 Size Estimates and Forecasts
2.1.1 Global Embolization Particle Revenue 2019-2030
2.1.2 Global Embolization Particle Sales 2019-2030
2.2 Embolization Particle 麻豆原创 Size by Region: 2023 Versus 2030
2.3 Embolization Particle Sales by Region (2019-2030)
2.3.1 Global Embolization Particle Sales by Region: 2019-2024
2.3.2 Global Embolization Particle Sales Forecast by Region (2025-2030)
2.3.3 Global Embolization Particle Sales 麻豆原创 Share by Region (2019-2030)
2.4 Embolization Particle 麻豆原创 Estimates and Projections by Region (2025-2030)
2.4.1 Global Embolization Particle Revenue by Region: 2019-2024
2.4.2 Global Embolization Particle Revenue Forecast by Region (2025-2030)
2.4.3 Global Embolization Particle Revenue 麻豆原创 Share by Region (2019-2030)
3 Global Embolization Particle by Manufacturers
3.1 Global Top Embolization Particle Manufacturers by Sales
3.1.1 Global Embolization Particle Sales by Manufacturer (2019-2024)
3.1.2 Global Embolization Particle Sales 麻豆原创 Share by Manufacturer (2019-2024)
3.2 Global Top Embolization Particle Manufacturers by Revenue
3.2.1 Global Embolization Particle Revenue by Manufacturer (2019-2024)
3.2.2 Global Embolization Particle Revenue Share by Manufacturer (2019-2024)
3.3 Global Embolization Particle Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Embolization Particle Manufacturers Covered: Ranking by Revenue
3.4.2 Global Embolization Particle 麻豆原创 Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Embolization Particle 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Embolization Particle Manufacturing Base Distribution, Product Type
3.5.1 Embolization Particle Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Embolization Particle Product Type
3.5.3 Date of International Manufacturers Enter into Embolization Particle 麻豆原创
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Sirtex Medical
4.1.1 Sirtex Medical Company Information
4.1.2 Sirtex Medical Description, Business Overview
4.1.3 Sirtex Medical Embolization Particle Products Offered
4.1.4 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Sirtex Medical Embolization Particle Sales by Product in 2023
4.1.6 Sirtex Medical Embolization Particle Sales by Application in 2023
4.1.7 Sirtex Medical Embolization Particle Sales by Geographic Area in 2023
4.1.8 Sirtex Medical Recent Developments
4.2 Merit Medical
4.2.1 Merit Medical Company Information
4.2.2 Merit Medical Description, Business Overview
4.2.3 Merit Medical Embolization Particle Products Offered
4.2.4 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Merit Medical Embolization Particle Sales by Product in 2023
4.2.6 Merit Medical Embolization Particle Sales by Application in 2023
4.2.7 Merit Medical Embolization Particle Sales by Geographic Area in 2023
4.2.8 Merit Medical Recent Developments
4.3 Cook Medical
4.3.1 Cook Medical Company Information
4.3.2 Cook Medical Description, Business Overview
4.3.3 Cook Medical Embolization Particle Products Offered
4.3.4 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Cook Medical Embolization Particle Sales by Product in 2023
4.3.6 Cook Medical Embolization Particle Sales by Application in 2023
4.3.7 Cook Medical Embolization Particle Sales by Geographic Area in 2023
4.3.8 Cook Medical Recent Developments
4.4 BTG Medical
4.4.1 BTG Medical Company Information
4.4.2 BTG Medical Description, Business Overview
4.4.3 BTG Medical Embolization Particle Products Offered
4.4.4 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
4.4.5 BTG Medical Embolization Particle Sales by Product in 2023
4.4.6 BTG Medical Embolization Particle Sales by Application in 2023
4.4.7 BTG Medical Embolization Particle Sales by Geographic Area in 2023
4.4.8 BTG Medical Recent Developments
4.5 Boston Scientific Corporation
4.5.1 Boston Scientific Corporation Company Information
4.5.2 Boston Scientific Corporation Description, Business Overview
4.5.3 Boston Scientific Corporation Embolization Particle Products Offered
4.5.4 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Boston Scientific Corporation Embolization Particle Sales by Product in 2023
4.5.6 Boston Scientific Corporation Embolization Particle Sales by Application in 2023
4.5.7 Boston Scientific Corporation Embolization Particle Sales by Geographic Area in 2023
4.5.8 Boston Scientific Corporation Recent Developments
4.6 Terumo Corporation
4.6.1 Terumo Corporation Company Information
4.6.2 Terumo Corporation Description, Business Overview
4.6.3 Terumo Corporation Embolization Particle Products Offered
4.6.4 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Terumo Corporation Embolization Particle Sales by Product in 2023
4.6.6 Terumo Corporation Embolization Particle Sales by Application in 2023
4.6.7 Terumo Corporation Embolization Particle Sales by Geographic Area in 2023
4.6.8 Terumo Corporation Recent Development
4.7 HENGRUI Medical
4.7.1 HENGRUI Medical Company Information
4.7.2 HENGRUI Medical Description, Business Overview
4.7.3 HENGRUI Medical Embolization Particle Products Offered
4.7.4 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
4.7.5 HENGRUI Medical Embolization Particle Sales by Product in 2023
4.7.6 HENGRUI Medical Embolization Particle Sales by Application in 2023
4.7.7 HENGRUI Medical Embolization Particle Sales by Geographic Area in 2023
4.7.8 HENGRUI Medical Recent Development
4.8 INterface BIOmaterials B.V.
4.8.1 INterface BIOmaterials B.V. Company Information
4.8.2 INterface BIOmaterials B.V. Description, Business Overview
4.8.3 INterface BIOmaterials B.V. Embolization Particle Products Offered
4.8.4 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
4.8.5 INterface BIOmaterials B.V. Embolization Particle Sales by Product in 2023
4.8.6 INterface BIOmaterials B.V. Embolization Particle Sales by Application in 2023
4.8.7 INterface BIOmaterials B.V. Embolization Particle Sales by Geographic Area in 2023
4.8.8 INterface BIOmaterials B.V. Recent Development
4.9 Alicon
4.9.1 Alicon Company Information
4.9.2 Alicon Description, Business Overview
4.9.3 Alicon Embolization Particle Products Offered
4.9.4 Alicon Embolization Particle Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Alicon Embolization Particle Sales by Product in 2023
4.9.6 Alicon Embolization Particle Sales by Application in 2023
4.9.7 Alicon Embolization Particle Sales by Geographic Area in 2023
4.9.8 Alicon Recent Development
5 Breakdown Data by Type
5.1 Global Embolization Particle Sales by Type (2019-2030)
5.1.1 Global Embolization Particle Sales by Type (2019-2024)
5.1.2 Global Embolization Particle Sales Forecast by Type (2025-2030)
5.1.3 Global Embolization Particle Sales 麻豆原创 Share by Type (2019-2030)
5.2 Global Embolization Particle Revenue Forecast by Type (2019-2030)
5.2.1 Global Embolization Particle Revenue by Type (2019-2024)
5.2.2 Global Embolization Particle Revenue Forecast by Type (2025-2030)
5.2.3 Global Embolization Particle Revenue 麻豆原创 Share by Type (2019-2030)
5.3 Embolization Particle Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Embolization Particle Sales by Application (2019-2030)
6.1.1 Global Embolization Particle Sales by Application (2019-2024)
6.1.2 Global Embolization Particle Sales Forecast by Application (2025-2030)
6.1.3 Global Embolization Particle Sales 麻豆原创 Share by Application (2019-2030)
6.2 Global Embolization Particle Revenue Forecast by Application (2019-2030)
6.2.1 Global Embolization Particle Revenue by Application (2019-2024)
6.2.2 Global Embolization Particle Revenue Forecast by Application (2025-2030)
6.2.3 Global Embolization Particle Revenue 麻豆原创 Share by Application (2019-2030)
6.3 Embolization Particle Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Embolization Particle 麻豆原创 Size YoY Growth 2019-2030
7.2 North America Embolization Particle 麻豆原创 Facts & Figures by Country
7.2.1 North America Embolization Particle Sales by Country (2019-2030)
7.2.2 North America Embolization Particle Revenue by Country (2019-2030)
7.3 North America Embolization Particle Sales by Type (2019-2024)
7.4 North America Embolization Particle Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Embolization Particle 麻豆原创 Size YoY Growth 2019-2030
8.2 Asia-Pacific Embolization Particle 麻豆原创 Facts & Figures by Region
8.2.1 Asia-Pacific Embolization Particle Sales by Region (2019-2030)
8.2.2 Asia-Pacific Embolization Particle Revenue by Region (2019-2030)
8.3 Asia-Pacific Embolization Particle Sales by Type (2019-2024)
8.4 Asia-Pacific Embolization Particle Sales by Application (2019-2024)
9 Europe
9.1 Europe Embolization Particle 麻豆原创 Size YoY Growth 2019-2030
9.2 Europe Embolization Particle 麻豆原创 Facts & Figures by Country
9.2.1 Europe Embolization Particle Sales by Country (2019-2030)
9.2.2 Europe Embolization Particle Revenue by Country (2019-2030)
9.3 Europe Embolization Particle Sales by Type (2019-2024)
9.4 Europe Embolization Particle Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Embolization Particle 麻豆原创 Size YoY Growth 2019-2030
10.2 Latin America Embolization Particle 麻豆原创 Facts & Figures by Country
10.2.1 Latin America Embolization Particle Sales by Country (2019-2030)
10.2.2 Latin America Embolization Particle Revenue by Country (2019-2030)
10.3 Latin America Embolization Particle Sales by Type (2019-2024)
10.4 Latin America Embolization Particle Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Embolization Particle 麻豆原创 Size YoY Growth 2019-2030
11.2 Middle East and Africa Embolization Particle 麻豆原创 Facts & Figures by Country
11.2.1 Middle East and Africa Embolization Particle Sales by Country (2019-2030)
11.2.2 Middle East and Africa Embolization Particle Revenue by Country (2019-2030)
11.3 Middle East and Africa Embolization Particle Sales by Type (2019-2024)
11.4 Middle East and Africa Embolization Particle Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Embolization Particle Supply Chain Analysis
12.2 Embolization Particle Key Raw Materials and Upstream Suppliers
12.3 Embolization Particle Clients Analysis
12.4 Embolization Particle Sales Channel and Sales Model Analysis
12.4.1 Embolization Particle Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Embolization Particle Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Embolization Particle Distributors
13 麻豆原创 Dynamics
13.1 Embolization Particle Industry Trends
13.2 Embolization Particle 麻豆原创 Drivers
13.3 Embolization Particle 麻豆原创 Challenges
13.4 Embolization Particle 麻豆原创 Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
听
听
*If Applicable.